Somber
发表于 2025-3-28 15:07:03
Preoperative Therapy for Operable Breast CancerC provides an ideal setting in which the responsiveness of a given treatment can be observed and provides relevant information on the biology of the tumor by enabling biomarker analysis. Accumulating data on the strong association with survival and pathological complete response (pCR) may lead to a
vertebrate
发表于 2025-3-28 20:35:32
Systemic Therapy for Inflammatory Breast Cancerl rates range from 46 % to 61 % and 15-year survival rates vary between 20 % and 30 %. The response to primary chemotherapy is a strong indicator of survival. The 15-year survival rate is 44 % in patients who achieve a pathological complete response after primary chemotherapy. In this chapter, preop
OREX
发表于 2025-3-29 00:11:11
http://reply.papertrans.cn/20/1906/190592/190592_43.png
Indecisive
发表于 2025-3-29 05:49:52
y perspective on breast diseases.Contributions from an international team of experts present invaluable insightinto clinical practice across different settings. Covering both theoretical andpractical aspects of978-3-319-26012-9
Ingrained
发表于 2025-3-29 10:56:13
http://reply.papertrans.cn/20/1906/190592/190592_45.png
Archipelago
发表于 2025-3-29 12:44:26
Advances in Intelligent and Soft Computingof ongoing TNM staging to determine whether to apply systemic therapy based on anatomic prognosis. Although multigene expression assays, such as the 70-gene prognostic signature or Oncotype DX tests, may provide additional prognostic and predictive information beyond anatomic TNM staging and ER/PR a
–LOUS
发表于 2025-3-29 18:32:48
http://reply.papertrans.cn/20/1906/190592/190592_47.png
少量
发表于 2025-3-29 23:36:07
Alaa Sagheer,Saleh Aly,Samar Antergimen depends on the intrinsic subtype. Multigene expression array profiling is not always required for subtype definition after clinicopathological assessment. Young age, grade 3 disease, lymphovascular invasion, one to three positive nodes, and large tumor size are not adequate features to omit mo
blackout
发表于 2025-3-30 01:57:01
http://reply.papertrans.cn/20/1906/190592/190592_49.png
珐琅
发表于 2025-3-30 05:12:39
http://reply.papertrans.cn/20/1906/190592/190592_50.png